These effects were found to be mediated in part through a reduced expression of both PPARγ - a pro-adipogenic transcription factor – and leptin – an adipokine that was shown to promote cell-cycle progression and proliferation of PCa cells – after statin treatment. The gene discussed is LEP; the disease is posterior cortical atrophy.